Neoplasms, Unknown Primary

Oncology
1
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Heidelberg Pharma
Heidelberg PharmaGermany - Ladenburg
1 program
1
paclitaxel/carboplatinPhase 21 trial
Active Trials
NCT00894569Unknown150Est. Aug 2011
Genomics
GenomicsUK - Oxford
1 program
Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)N/A
Teva
TevaIsrael - Petach Tikva
1 program
Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)N/A1 trial
Active Trials
NCT01202786Completed60Est. Apr 2012
Orchard Therapeutics
1 program
Outcomes of FoundationOne Directed Therapy in Cancer of Unknown PrimaryN/A1 trial
Active Trials
NCT02628379CompletedEst. Mar 2017

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Heidelberg Pharmapaclitaxel/carboplatin
Orchard TherapeuticsOutcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary
TevaCost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

Clinical Trials (3)

Total enrollment: 210 patients across 3 trials

NCT00894569Heidelberg Pharmapaclitaxel/carboplatin

Paclitaxel/Carboplatin With or Without Cetuximab in CUP

Start: Jul 2009Est. completion: Aug 2011150 patients
Phase 2Unknown
NCT02628379Orchard TherapeuticsOutcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Outcomes of FoundationOne Directed Therapy in Cancer of Unknown Primary

Start: May 2015Est. completion: Mar 2017
N/ACompleted
NCT01202786TevaCost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

Cost-effectiveness Study of miRview™ Mets in Patients With Cancer of Unknown Primary (CUP)

Start: May 2010Est. completion: Apr 201260 patients
N/ACompleted

Related Jobs in Oncology

Senior Research Associate, Immuno-Oncology

SystImmune
3h ago
$60K - $85K/yr

Research Associate I/II, Immuno-Oncology

SystImmune
3h ago

Office Administrator

SystImmune
3h ago
$60K - $80K/yr

Scientist/Sr Scientist

TwoStep Therapeutics
San Carlos
3h ago

Senior Medical Project Manager (m/f/d)

Mindpeak
Hamburg
3h ago

Working Student Active Sourcing Support (m/f/d)

Mindpeak
Hamburg
3h ago

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

4 companies competing in this space

Related Indications

Breast Cancer(530)Non-small Cell Lung Cancer(373)Prostate Cancer(371)Multiple Myeloma(244)Advanced Solid Tumors(221)Acute Myeloid Leukemia(204)Cancer(187)Neoplasms(173)Colorectal Cancer(166)Advanced Solid Tumor(165)